Dynavax Technologies Corporation and GlaxoSmithKline Expand Their...

Oct 21, 2011 | Posted by: roboblogger | Full story: BioSpace

RKELEY, CA, Oct 21, 2011 -- Dynavax Technologies Corporation announced today the expansion of its worldwide strategic alliance with GlaxoSmithKline focused on toll-like receptor inhibitors.

1 - 1 of 1 Comments Last updated Oct 26, 2011

Melton Mowbray, UK

#1 Oct 26, 2011
the ecdysone (insect estrogen) receptor, a ligand-activated transcription factor found in the nuclei of insect cells. This in turn leads to the activation of many other genes and can cause many deseases such as TB!

Tell me when this thread is updated: (Registration is not required)

Add to my Tracker Send me an email

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Marketwire Discussions

Title Updated Last By Comments
More Than 300 Operators Now Using PeerApp Ultra... (Mar '13) Mar '13 Tony 1
Infortrend's Flagship ZFS-Based Nas Offers 8 GB... (Dec '12) Dec '12 Ernest Berkoh 1
Chick-Fil-A'd: Bully Fired After Video Goes Viral (Aug '12) Aug '12 TheBlackSheep 1
Abitibi Royalties Inc./Malartic CHL Joint Ventu... (Feb '12) Feb '12 Malartic 1
Orlando Chiropractor and Affinity Health & Well... (Jan '12) Feb '12 Washington Chiro 20
Benitec Biopharma and Medistem Technologies Suc... (Feb '12) Feb '12 Tanya Doyle 1
Judicial Watch Files Two Amicus Curiae Briefs W... (Feb '12) Feb '12 Excellent 2
Enter and win $5000

Marketwire People Search

Addresses and phone numbers for FREE